All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
7E12070

Optimizing targets and therapeutics in high risk and refractory multiple myeloma

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

  • Call for proposals

    FP7-HEALTH-2011-two-stage

  • Main participants

  • Contest type

    RP - Co-financing of EC programme

  • Contract ID

    MSMT-1840/2013-310

Alternative language

  • Project name in Czech

    Optimizing targets and therapeutics in high risk and refractory multiple myeloma

  • Annotation in Czech

    Multiple myeloma (MM) is an incurable disease with rapidly growing prevalence and poor prognosis. Consequently, it is the goal of OPTATIO consortium to seek out novel strategies for the development of novel diagnostic and therapeutic options. MM pathogenesis involves not only genetic changes within the tumour cells but also the emergence of supportive conditions by the bone marrow microenvironment (BMM). It is the goal of the project to establish preclinical in vitro and in vivo models of MM that include functionally relevant elements of the BMM. OPTATIO will analyse clinical data to correlate the presence of particular MM-BMM interactions with pathogenesis of MM with its intrinsic therapy resistance as well as with disease relapse due to development of acquired drug resistance.

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    FD - Oncology and haematology

  • CEP - secondary branch

    FP - Other medical fields

  • CEP - another secondary branch

    FR - Pharmacology and apothecary chemistry

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    30104 - Pharmacology and pharmacy<br>30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30204 - Oncology<br>30205 - Hematology<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30501 - Forensic science<br>30502 - Other medical science

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    Following the condition that the candidate of financial contribution was evaluated and afterwards selected by international provider in accordance with the rules of the program the Ministry of Education, Youth ans Sports does not realize the evaluation of project results. The project is evaluated only after its approval by an international provider.

Solution timeline

  • Realization period - beginning

    Jan 1, 2012

  • Realization period - end

    Dec 31, 2014

  • Project status

    U - Finished project

  • Latest support payment

    Mar 27, 2014

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP15-MSM-7E-U/01:1

  • Data delivery date

    Jul 2, 2015

Finance

  • Total approved costs

    2,334 thou. CZK

  • Public financial support

    2,334 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK